| Drug Name: | Amonafide (69408-81-7) |
|---|---|
| PubChem ID: | 50515 |
| SMILES: | CN(C)CCN1C(=O)C2=CC=CC3=CC(=CC(=C32)C1=O)N |
| InchiKey: | UPALIKSFLSVKIS-UHFFFAOYSA-N |
| Therapeutic Category: |
| Molecular Weight (dalton) | : | 283.331 |
| LogP | : | 1.5796 |
| Ring Count | : | 2 |
| Hydrogen Bond Acceptor Count | : | 4 |
| Hydrogen Bond Donor Count | : | 1 |
| Total Polar Surface Area | : | 66.64 |
This panel provides information on interacting drugs and their ADRs along with references
| Interacting drug | Toxicity | Interaction Type | Mechanism | Reference |
|---|
This panel provides drug-protein interaction and their ADRs along with references
| Toxicity | Interacting Protein | Mechanism | Reference |
|---|---|---|---|
| Mylelotoxicity (Rapid Acetylators) | N-acetyltransferase (P61599) | Mylelotoxicity (rapid acetylators) [ ADR Type 2 ] | Pharmacogenetics in cancer chemotherapy: balancing toxicity and response |
This panel provides drug-food interactions and their ADRs along with references
| Food | Toxicity | Reference |
|---|
This panel provides information on metabolites and their ADRs along with references
| Metabolite | Toxicity | Place of Metabolism | Mechanism | Reference |
|---|
This panel provides information on drug category
| Toxicity | Source |
|---|